Ardent Health Reports Third Quarter 2026 Results

Ardent Health reported Q3 2026 results with total revenue up 3.1% YoY to $1.625B. Net income was $45M, or $0.17 per diluted share, compared to a loss of $23M in Q3 2025. Adjusted EBITDA was $138M. The company raised its 2026 adjusted EBITDA guidance. Adjusted admissions increased 2.9% YoY, while total surgeries decreased 1.9%.

Original reporting
Published Nov 4, 2026, 9:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 9:18 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$ARDT
Bullish
high confidence
Mentioned
$ARDT
Relevance
7/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$ARDTBullishMed
01

Why it matters

The earnings beat and guidance raise provide fresh material for traders; the stock may see short‑term buying interest.

02

Market read

First‑time earnings disclosure with improved metrics; relevant for healthcare sector investors.

03

What to watch

Potential impact of the 2023 cybersecurity incident costs on future margins.

Relevance 7/10Novelty 8/10Timing: post‑release today

Background

Ardent Health (NYSE: ARDT) released its third‑quarter 2026 financial results, showing revenue growth, a swing to net income, and an upward revision to its FY adjusted EBITDA guidance.

Company-level read

Ticker impact

$ARDTBullishHigh confidence
Context

Q3 2026 earnings release with revenue growth, profit swing to net income and raised FY2026 adjusted EBITDA guidance.

Expected impact

likely upward pressure as investors price in improved earnings and higher guidance

Evidence & confidence

First report of earnings and guidance; earnings beat expectations and guidance raise are material for a mid‑cap healthcare stock.

Market effects

May lift peer healthcare REIT and hospital operators as earnings beat suggests sector resilience.

Limited to U.S. healthcare equities.

Low

Counterpoint

If guidance is overly optimistic, the stock could face downside on future earnings scrutiny.

Key entities

  • Ardent Health

    U.S. healthcare provider listed on NYSE.

Related articles

$ARDTMed

What Ardent Health (ARDT) Said on Its Q3 Earnings Call

Ardent Health (ARDT) reported Q3 earnings, highlighting a 9% increase in urgent care visits and a 400 basis point decline in physician referral leakage. Labor costs fell 4.3% YoY, and the company plans to sell a Kansas hospital for 11x EBITDA. Ardent generated $122M in Q3 operating cash flow and lowered its 2026 capital expenditure guidance. The company remains 85% contracted for 2027 and 75% for 2028, with negotiations described as contentious.

$ARDTHighAI 8/10

Ardent Health (ARDT) Q3 2026 Earnings Call Transcript

Ardent Health (ARDT) reported Q3 2026 adjusted EBITDA of $138M, up 1.5% from prior guidance. Revenue was $1.62B, with adjusted admissions up 2.9%. The company plans to divest a Kansas hospital at 11x EBITDA, enhancing margins by 40bps. Ardent's IMPACT program aims for $70M in savings this year, and it raised its EBITDA guidance midpoint by 1.5%.

$ARDTHigh

Ardent Health Reports Third Quarter 2026 Results

Ardent Health, Inc. (ARDT) filed an SEC Form 8-K — Results of Operations and Financial Condition. 1 Exhibit 99.1 Ardent Health Reports Third Quarter 2026 Results Brentwood, Tenn. ( November 4, 2026 ) – Ardent Health, Inc. (NYSE: ARDT) ("Ardent Health" or the "Company"), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced re

$ARDTMed

Ardent Health (ARDT) Q2 2026 Earnings Call Transcript

Ardent Health (ARDT) discussed its Q2 2026 earnings call, citing operational cost reductions under its IMPACT program, including a 42% contract labor spend cut and 0.7% year-over-year SWB growth. It expects 2026 savings to rise to over $70 million and raised adjusted EBITDA outlook by $5 million to $10 million from a June payer renewal. Virtual care via hellocare.ai reported 58% discharge completion in Texas and Idaho.